洁特生物
(688026)
| 流通市值：31.88亿 | | | 总市值：31.88亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 424,947,332.7 | 277,457,045.28 | 107,856,760.78 | 563,976,836.75 |
| 营业总成本 | 391,934,810.5 | 257,287,868.6 | 113,800,338.52 | 485,139,596.82 |
| 其他经营收益 | | | | |
| 营业利润 | 38,442,620.49 | 23,975,011.82 | -2,921,191.54 | 62,361,607.53 |
| 利润总额 | 39,291,350.1 | 24,012,931.08 | -2,899,272.43 | 60,934,056.25 |
| 净利润 | 34,545,544.12 | 22,037,218.52 | -3,836,337.39 | 49,094,610.55 |
| 每股收益 | | | | |
| 其他综合收益 | -701,124.96 | -638,800.05 | -89,482.93 | 301,690.5 |
| 综合收益总额 | 33,844,419.16 | 21,398,418.47 | -3,925,820.32 | 49,396,301.05 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 790,614,723.58 | 791,580,892.95 | 785,535,438.45 | 809,533,876.63 |
| 非流动资产: | | | | |
| 非流动资产合计 | 961,814,635.35 | 941,391,632.38 | 930,833,692.35 | 931,794,222.14 |
| 资产总计 | 1,752,429,358.93 | 1,732,972,525.33 | 1,716,369,130.79 | 1,741,328,098.77 |
| 流动负债: | | | | |
| 流动负债合计 | 96,244,250.53 | 102,094,040.38 | 96,456,243.76 | 107,582,570.3 |
| 非流动负债: | | | | |
| 非流动负债合计 | 435,555,289.89 | 422,696,444.84 | 417,113,536.8 | 408,585,831.11 |
| 负债合计 | 531,799,540.42 | 524,790,485.22 | 513,569,780.56 | 516,168,401.41 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,208,961,968.63 | 1,195,735,347.86 | 1,192,546,446.14 | 1,216,301,466.2 |
| 股东权益合计 | 1,220,629,818.51 | 1,208,182,040.11 | 1,202,799,350.23 | 1,225,159,697.36 |
| 负债和股东权益合计 | 1,752,429,358.93 | 1,732,972,525.33 | 1,716,369,130.79 | 1,741,328,098.77 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 492,226,389.62 | 325,981,771.69 | 155,461,673.03 | 699,465,606.55 |
| 经营活动现金流出小计 | 412,007,950.66 | 290,877,488.71 | 134,190,509.95 | 507,705,964.72 |
| 经营活动产生的现金流量净额 | 80,218,438.96 | 35,104,282.98 | 21,271,163.08 | 191,759,641.83 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 906,738,922.91 | 634,433,591.48 | 356,065,600 | 1,016,847,151.26 |
| 投资活动现金流出小计 | 992,814,487.64 | 657,828,657.28 | 365,050,726.79 | 1,065,427,583.57 |
| 投资活动产生的现金流量净额 | -86,075,564.73 | -23,395,065.8 | -8,985,126.79 | -48,580,432.31 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,360,000 | 1,360,000 | - | 890,000 |
| 筹资活动现金流出小计 | 49,562,821.73 | 38,080,090.31 | 18,808,175.44 | 16,359,428.23 |
| 筹资活动产生的现金流量净额 | -48,202,821.73 | -36,720,090.31 | -18,808,175.44 | -15,469,428.23 |
| 汇率变动对现金及现金等价物的影响 | -12,008,470.27 | -9,336,091.65 | -4,843,367.34 | -2,154,555.92 |
| 现金及现金等价物净增加额 | -66,068,417.77 | -34,346,964.78 | -11,365,506.49 | 125,555,225.37 |
| 期末现金及现金等价物余额 | 177,882,084.98 | 209,603,537.97 | 232,584,996.26 | 243,950,502.75 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -34,346,964.78 | - | 125,555,225.37 |